Viracta Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Dec 23 | Buy€45,447 | Mark Rothera | Individual | 100,000 | €0.45 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 8,889 | 0.0226% |
Individual Insiders | 1,025,507 | 2.61% |
Hedge Funds | 3,614,662 | 9.2% |
Institutions | 6,933,846 | 17.7% |
VC/PE Firms | 9,959,759 | 25.4% |
General Public | 17,729,771 | 45.1% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,392,237 | €4.7m | 0% | 6.94% | |||
3,614,662 | €2.3m | 0% | 0.06% | |||
2,567,522 | €1.6m | 0% | 100.0% | |||
1,565,202 | €985.3k | 2.36% | no data | |||
1,161,280 | €731.1k | 0% | no data | |||
1,154,012 | €726.5k | 0% | 0.04% | |||
807,902 | €508.6k | 3.22% | no data | |||
689,709 | €434.2k | 0% | 0.1% | |||
420,426 | €264.7k | -25.3% | 0.01% | |||
364,097 | €229.2k | 2.43% | no data | |||
303,980 | €191.4k | -0.55% | no data | |||
288,571 | €181.7k | 0% | 0.07% | |||
252,701 | €159.1k | 0% | no data | |||
202,499 | €127.5k | 13.2% | no data | |||
118,016 | €74.3k | 35.1% | no data | |||
109,195 | €68.7k | 6.73% | no data | |||
108,410 | €68.2k | 9.09% | no data | |||
74,000 | €46.6k | 0% | no data | |||
65,867 | €41.5k | 0% | no data | |||
63,406 | €39.9k | 0% | no data | |||
38,190 | €24.0k | 4.74% | no data | |||
25,200 | €15.9k | 0% | no data | |||
17,500 | €11.0k | 0% | no data | |||
16,988 | €10.7k | 44.6% | no data | |||
15,000 | €9.4k | 50% | no data |